$BSX · Boston Scientific Corporation
Boston Scientific Corporation filed a Form 4 with the SEC reporting changes in beneficial ownership for Miriam O'Sullivan, the company's SVP and Chief HR Officer. The filing covers transactions dated November 1, 2026. On that date, 3,871 restricted stock units vested and were converted into 3,871 shares of Boston Scientific common stock at no cost. In a related transaction, 1,872 of those shares were withheld by the company to cover tax obligations, valued at $41.98 per share.
Following these transactions, O'Sullivan directly held 19,565 shares of common stock. The filing also notes that she indirectly held 1,731 shares through her spouse. The restricted stock units that vested were originally scheduled to be issued in full on November 1, 2026, the third anniversary of the grant date. The Form 4 was signed on November 3, 2026, by an attorney-in-fact on behalf of the reporting person.